Nasdaq · Healthcare
ACCURAY INC (ARAY)
As-reported financials and recent SEC filings for ACCURAY INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$458.5M
Net income
$-1.6M
Net margin
-0.3%
Diluted EPS
$-0.02
ROE
-2.0%
P/E (TTM)
—
Market cap
$31.5M
Debt / equity
1.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $458.5M | $446.6M | $447.6M | $429.9M | $396.3M |
| Gross profit | $147.0M | $142.9M | $154.0M | $160.0M | $159.5M |
| Operating income | $7.8M | $504,000 | $2.4M | $8.1M | $22.2M |
| Net income | $-1.6M | $-15.5M | $-9.3M | $-5.3M | $-6.3M |
| Diluted EPS | $-0.02 | $-0.16 | $-0.10 | $-0.06 | $-0.07 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-12
View on EDGAR →8-K2026-06-04
View on EDGAR →SD2026-05-29
View on EDGAR →S-82026-05-29
View on EDGAR →42026-05-29
View on EDGAR →SCHEDULE 13D/A2026-05-22
View on EDGAR →42026-05-21
View on EDGAR →10-Q2026-05-06
View on EDGAR →Go deeper on ARAY
Search ACCURAY INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.